检测猪繁殖与呼吸综合征抗体的重组N蛋白一乳胶凝集试验的建立

猪繁殖与呼吸综合征(Poreine Reproductive and Respiratory Syndrome,PRRS)于1987年首先在美国被发现,现在已经成为危害世界养猪业发展的重要传染病之一.我国已在许多地区分离到该病的病原体-猪繁殖与呼吸综合征病毒(Porcine reproductive and respiratory syndrome viruS,PRRSV),从而证实了该病在我国的流行[1～4].这些年来,本病的临诊表现及流行病学也出现了新的变化,如隐性感染及慢性感染病例显著上升,持续性感染在猪群中较为普遍.由于本病同其它引起猪繁殖障碍的疾病(如猪细小病毒病、伪狂犬病等)表现出极为相似的临床症状,并伴随混合感染和继发感染[5]增加了临床诊断的难度.所以,探索一种简便易行具有推广意义的检测方法成为本研究的方向.     

实时荧光定量PCR在猪繁殖与呼吸综合征病毒研究中的应用

猪繁殖与呼吸综合征病毒(porcine reproductive and respiratory syndrome virus,PRRSV)是一种严重危害种公猪和繁殖母猪及其仔猪的一种接触性传染病,是我国重要猪病病原体之一。建立一种快速、可靠的诊断方法,对于控制和消灭PRRSV至关重要。实时荧光定量PCR技术的发展为PRRSV在快速检测和鉴别诊断方面开辟了新思路。以下回顾了实时荧光定量PCR操作技术在PRRSV研究应用方面的研究进展,同时提出了该领域目前面临的问题,并对其未来发展方向进行了展望。     

猪繁殖与呼吸综合征病毒N基因和流感病毒HA基因的联合表达及应用

参照已公布的流感病毒血凝素基因(HA基因)及猪繁殖与呼吸综合征病毒(PRRSV)基因组序列,设计并合成一对引物P1、P2,以RT-PCR方法扩增出PRRSV的ORF7片段(约410bp),其中含HA基因主要核苷酸序列(33bp).用BamH I、Xho I分别对扩增出的片段及pET32a质粒进行酶切,连接后构建了重组质粒pETHN并转化到BL21(DE3)宿主菌中诱导表达.用纯化后的表达产物与流感病毒血凝素单抗及乳胶建立了诊断猪繁殖与呼吸综合征(PRRS)的乳胶凝集试验.检测结果显示该方法有良好的特异性及敏感性,与IDEXX公司ELISA检测试剂盒符合率达93.8%.     

猪繁殖与呼吸综合征病毒N基因和流感病毒HA基因的联合表达及应用

参照已公布的流感病毒血凝素基因(HA基因)及猪繁殖与呼吸综合征病毒(PRRSV)基因组序列,设计并合成一对引物P1、P2,以RT-PCR方法扩增出PRRSV的ORF7片段(约410bp),其中含HA基因主要核苷酸序列(33bp)。用BamH Ⅰ、Xho Ⅰ分别对扩增出的片段及pET32a质粒进行酶切,连接后构建了重组质粒pETHN并转化到BL21(DE3)宿主菌中诱导表达。用纯化后的表达产物与流感病毒血凝素单抗及乳胶建立了诊断猪繁殖与呼吸综合征(PRRS)的乳胶凝集试验。检测结果显示:该方法有良好的特异性及敏感性,与IDEXX公司FLISA检测试剂盒符合率达93.8％。     

猪繁殖与呼吸综合征病毒实时PCR检测方法的建立

设计合成了一套引物和TaqMan探针,以扩增猪繁殖与呼吸综合征病毒的核衣壳蛋白基因,通过反应条件的优化,在国内首次建立了快速定量检测猪繁殖与呼吸综合征病毒的实时PCR方法,并用该法检测患病猪的肺脏等样品。结果表明该方法具有较好的特异性和重复性,对PRRSV细胞培养物的检测下限为0.01TCID50,敏感性比常规RT-PCR高100倍;对10份PRRS疑似猪肺脏样品检测5份为阳性,与病毒分离的阳性符合率为100%。该方法具有快速、灵敏、准确、低污染等优点,在PRRSV的早期检测、预防控制、进出口检疫及基础研究中会起到重要作用。     

猪繁殖与呼吸综合征病毒Ⅳ基因和流感病毒HA基因的联合表达及应用

参照已公布的流感病毒血凝素基因(HA基因)及猪繁殖与呼吸综合征病毒(PRRSV)基因组序列,设计并合成一对引物P1、P2,以RT-PCR方法扩增出PRRSV的ORF7片段(约410bp),其中含HA基因主要核苷酸序列(33bp)。用BamHⅠ、Xho Ⅰ分别对扩增出的片段及pET32a质粒进行酶切,连接后构建了重组质粒pETHN并转化到BL21(DE3)宿主菌中诱导表达。用纯化后的表达产物与流感病毒血凝素单抗及乳胶建立了诊断猪繁殖与呼吸综合征(PRRS)的乳胶凝集试验。检测结果显示：该方法有良好的特异性及敏感性,与IDEXX公司ELISA检测试剂盒符合率达93.8％。     

猪繁殖与呼吸综合征病毒实时PCR检测方法的建立

设计合成了一套引物和TaqMan探针,以扩增猪繁殖与呼吸综合征病毒的核衣壳蛋白基因,通过反应条件的优化,在国内首次建立了快速定量检测猪繁殖与呼吸综合征病毒的实时PCR方法,并用该法检测患病猪的肺脏等样品.结果表明该方法具有较好的特异性和重复性,对PRRSV细胞培养物的检测下限为0.01TCID50,敏感性比常规RT-PCR高100倍;对10份PRRS疑似猪肺脏样品检测5份为阳性,与病毒分离的阳性符合率为100%.该方法具有快速、灵敏、准确、低污染等优点,在PRRSV的早期检测、预防控制、进出口检疫及基础研究中会起到重要作用.     

猪繁殖与呼吸综合征病毒分子生物学研究进展

猪繁殖与呼吸综合征是由猪繁殖与呼吸综合征病毒(PRRSV)诱发的一种接触性传染病,其症状主要表现为怀孕母猪流产、早产、产死胎、木乃伊胎及成年猪的呼吸道症状。本病自1987年在美国爆发后,给世界养猪业造成巨大损失。近年来,由于其危害性大而引起专家学者的关注,PRRS在分子生物学方面研究者较多。就其病原特性,基因结构,病毒蛋白,分子生物学诊断以及PRRS基因工程疫苗的研究等方面进行论述。     

应用RT-PCR检测流产胎儿组织中猪繁殖与呼吸综合征病毒

根据猪繁殖与呼吸综合征病毒(PRRSV)美洲型膜蛋白和核衣壳蛋白基因序列,设计了一对含有EcoR I和BamH I酶切位点的引物,用RT-PCR对四个流产猪场的病料进行了检测,扩增出约918 bp的基因片段.通过病毒分离、酶切鉴定和序列分析证实为PRRSV感染.结果说明应用所设计的引物进行RT-PCR快速检测PRRS是可行的,为我国快速特异诊断PRRS和PRRSV强毒株的深入研究奠定了基础.     

猪繁殖与呼吸综合症病毒GP5蛋白原核表达初步研究

猪繁殖与呼吸综合症是由猪繁殖与呼吸综合症病毒(Porcine reprodutive and respiratory syndrome virus,PRRSV)引发的病毒性传染病,病症主要表现为怀孕母猪早产、流产、木乃伊胎以及仔猪呼吸症状和高死亡率[1,2].该病于1987年首先在美国爆发[3],1990年德国亦发现此病,并迅速传播到欧洲其他国家.我国在1996年报道有该病流行[4],由于该病的迅速蔓延使整个世界养猪业遭受了巨大的经济损失.     

Laboratory diagnosis of SARS

The emergence of new viral infections of man requires the development of robust diagnostic tests that can be applied in the differential diagnosis of acute illness, or to determine past exposure, so as to establish the true burden of disease. Since the recognition in April 2003 of the severe acute respiratory syndrome coronavirus (SARS-CoV) as the causative agent of severe acute respiratory syndrome (SARS), enormous efforts have been applied to develop molecular and serological tests for SARS which can assist rapid detection of cases, accurate diagnosis of illness and the application of control measures. International progress in the laboratory diagnosis of SARS-CoV infection during acute illness has led to internationally agreed World Health Organization criteria for the confirmation of SARS. Developments in the dissection of the human immune response to SARS indicate that serological tests on convalescent sera are essential to confirm SARS infection, given the sub-optimal predictive value of molecular detection tests performed during acute SARS illness.     

Update on Diagnosis of Pneumocystis Pulmonary Infections

Pneumocystis jirovecii is a widespread fungal colonizer of the human lung. Proliferation of the pathogen in the alveoli is controlled by the immune system in healthy individuals. When the immune system is impaired, pneumocystosis can emerge, resulting in a pulmonary infection. Formerly, the disease occurred mainly in acquired immune deficiency syndrome (AIDS) patients, accompanied by a high mortality. Now it is increasingly seen in patients with immunosuppressive treatment. Traditionally, laboratory diagnosis is based on the microscopic detection of cysts and trophic forms of P. jirovecii in respiratory samples. Quantitative PCR-based methods will revolutionize laboratory diagnosis. However, cutoffs have to be established to discriminate between colonization (clinically irrelevant) and infection. Furthermore, the data on the serological detection of (1→3)-ß-D-glucan to diagnose or exclude pneumocystosis is promising.     

Mycoplasma pneumoniae respiratory disease symposium: summation and significance

The symposium on M. pneumoniae respiratory disease has examined the clinical expression of infection in adults and children, the pathophysiologic disturbances which occur, and the laboratory diagnosis by isolation and serology. That these infections are very common has been well documented; however, a variable incidence over periods of several years tends to minimize importance of the disease for many clinicians. While good laboratory diagnostic methods exist, they provide retrospective insight predominantly and are not useful for early diagnosis or therapeutic decision making. Development of rapid diagnostic methods which are sensitive and specific is an important goal for future research. Success would facilitate our understanding and control of M. pneumoniae disease.     

肺炎支原体实验室检测方法研究进展

肺炎支原体(Mycoplosma pneumonia,MP)为人类非典型肺炎的病原体,是引起呼吸道感染的重要病原体。但是支原体肺炎与其他病原体感染的肺炎,在临床症状、影像学上并无特异性差别,且其对一般治疗肺炎、上呼吸道感染的药物有耐药性,因此肺炎支原体及时、准确的实验室检测对于支原体肺炎的诊断治疗显得尤为重要。目前MP的实验室检测方法不断推陈出新,但各种方法均有其优势与不足,临床可选择两种不同的方法同时检测。比如:血清学抗体的检测结合MP快速培养药敏的方法;血清学抗体的检测结合PCR的方法,不同方法相互补充为临床的早期诊断、治疗提供依据。而MP药敏试验的检测和耐药机制的研究对于临床用药方案的选择,减少耐药株的产生和流行具有重要意义。     

胆管癌诊断的分子生物学标志研究进展

胆管癌(cholangiocarcinoma, CCA)是第二常见的原发性肝脏恶性肿瘤。由于该病症隐匿,早期诊断困难,大多数患者在晚期才被发现且患者预后较差,因此早期诊断成为胆管癌治疗的关键。分子生物学标志可以标记系统、器官、组织、细胞及亚细胞结构及其功能的改变。大量研究表明,某些分子生物学标记物的检测有助于CCA的早期诊断,故本文旨在总结与CCA诊断相关的分子生物学标记物及其研究进展。     

Porcine reproductive and respiratory syndrome virus

Porcine reproductive and respiratory disease (PRRS) is an economically important disease around the globe; it has been estimated to cost the swine industry in USA approximately 560 million US dollars annually. It is well established that PRRS is caused by an enveloped, single-stranded positive-sense RNA virus known as porcine reproductive and respiratory syndrome virus (PRRSV). The inability to successfully control PRRS across farms via traditional methods (e.g. vaccine and animal flow) has led to a growing interest in area-based eradication. Important to such an initiative is information on PRRSV transmission within and between herds and intervention strategies to prevent its spread. This paper will review the current literature on selected areas of PRRS known to be important to the topic of pathogen elimination, including etiology, clinical manifestations, direct and indirect routes of transmission, as well as discuss measures for disease control, prevention and eradication.     

The rapid diagnosis of salmonellosis by a determination of the antigen in the biosubstrates of patients using the coagglutination reaction]

The diagnostic potential of the coagglutination test was checked with the aim of improving the laboratory diagnosis of Salmonella infections by the detection of Salmonella specific antigen in different biological materials (feces, urine, saliva and immune complexes in blood sera). The study of all specimens resulted in the confirmation of the diagnosis in 78% of patients, often during the first days of the disease. The proportion of nonspecific reactions, as shown in the control groups of healthy donors and patients with dysentery and other acute enteric infections, did not exceed 5%.     

COVID-19检测技术的优点和局限性

由严重急性呼吸系统综合症冠状病毒2(severe acute respiratory syndrome coronavirus 2,SARS-CoV-2)感染引起的2019年冠状病毒肺炎(COVID-19),其持续大流行已对世界公共卫生安全造成严重的危害。发展病毒检测技术并运用于卫生管理包括人员排查、患者鉴别与治疗、减缓病毒传播等方面已发挥了重要作用。本文简要概述了SARS-CoV-2生物学特征,对全球发展使用的SARS-CoV-2病毒主要检测技术和新兴发展检测技术进行了比较详尽的介绍,并对病毒检测技术进行了展望,以期为临床医疗诊断、公共卫生防护、疾病预防和控制等提供理论和技术帮助。